Pfizer Will Merge Off-Patent Unit With Mylan

WSJ What’s News - En podkast av The Wall Street Journal

Prøv Podimo gratis i hele 60! dager!

I Podimo finner du eksklusive podkaster og bestselgende lydbøker tilpasset dine ører

P.M. Edition for July 29: Pfizer, maker of Lipitor and Viagra, plans to merge its off-patent drug business with Mylan, which makes the EpiPen. The Wall Street Journal's Jonathan Rockoff says it's a bid to reignite sales growth.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Visit the podcast's native language site